Nasdaq

Gain Therapeutics Appoints New CEO Amidst Clinical Progress

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Gain Therapeutics ( ...
Nasdaq

Gain Therapeutics, Inc. Reports Q1 2025 Financial Results and Corporate Update, Highlights Progress in Parkinson’s Disease Drug Development

Gain Therapeutics reports Q1 2025 financial results, progressing Phase 1b study of Parkinson's treatment GT-02287, with FDA engagement anticipated. Successful administration of GT-02287, a lead drug ...
Healthline

How Long Does It Take to Gain Weight?

enhancing sports performance putting on muscle to reach a fitness or aesthetic goal recovering from a serious illness restoring weight after unintentional or undesired weight loss improving hormone ...
ascopubs.org

Does absolute gain in progression-free survival (PFS) half-life (t½) translate into absolute overall survival (OS) benefit?

Natural history of heparin-induced thrombocytopenia (HIT) in the cancer population. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include a full text ...